Skip to main content
رجوع
Watch Compare

NANOVIRICIDES, INC.

جودة البيانات: 83%
NNVC
NYSE Manufacturing Chemicals
KWD 1.06
▼ KWD 0.04 (-3.64%)
القيمة السوقية: 22.89 M
السعر
KWD 1.06
القيمة السوقية
22.89 M
نطاق اليوم
KWD 1.01 — KWD 1.11
نطاق 52 أسبوعًا
KWD 0.85 — KWD 2.23
حجم التداول
159,223
فتح KWD 1.11
متوسط 50 يوم / 200 يوم
KWD 1.00
5.70% above
متوسط 50 يوم / 200 يوم
KWD 1.32
19.52% below

Quick Summary

النقاط الرئيسية

Negative free cash flow of -7.43 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-91.18%
أقل من متوسط القطاع (-53.47%)
ROIC-72.69%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio4.43
Interest Coverage-168.54

التقييم

PE (TTM)
-2.75
أقل من متوسط القطاع (-1.47)
P/B Ratio2.07
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -2.8 -1.5
P/B 2.1 1.6
ROE % -91.2 -53.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

ETFs Holding This Stock

BRSIX BRSIX
0.05% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -8.32 M
ROE -91.18% ROA -80.66%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -7.43 M
ROIC -72.69% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4.43
Interest Coverage -168.54 Asset Turnover N/A
Working Capital 4.10 M Tangible Book Value 10.76 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.75 Forward P/E N/A
P/B Ratio 2.07 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -32.46%
Market Cap 22.89 M Enterprise Value 17.74 M
Per Share
EPS (Diluted TTM) -0.49 Revenue / Share N/A
FCF / Share -0.34 OCF / Share -0.34
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 89.33%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -9.47 M -8.29 M -8.59 M -8.11 M -8.82 M
EPS (Diluted) -0.63 -0.70 -0.74 -0.70 —
Gross Profit — — — — —
Operating Income -9.59 M -8.52 M -8.94 M -8.11 M -8.74 M
EBITDA — — — — —
R&D Expenses 5.55 M 5.44 M 6.39 M 5.78 M 6.11 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 49,808.0 49,808.0 938.0 5,123.0 85,405.0
Income Tax — — — — 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8.82 M 12.82 M 16.90 M 23.49 M 30.26 M
Total Liabilities 1.30 M 1.36 M 2.03 M — —
Shareholders' Equity 7.52 M 11.46 M 14.87 M 23.08 M 29.91 M
Total Debt — — — — —
Cash & Equivalents 1.56 M 4.80 M 8.15 M 14.07 M 20.52 M
Current Assets 1.67 M 4.97 M 8.45 M 14.42 M 20.82 M
Current Liabilities 1.31 M 1.36 M 534,250.0 412,837.0 351,146.0